These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5626572)

  • 21. [ON HORMONAL CONTROL OF FUNCTIONAL MENO-METRORRHAGIAS (CLINICAL AND HISTOLOGICAL RESEARCH)].
    MARAZZINI F; PAGANI C
    Ann Ostet Ginecol; 1964 Jan; 86():67-82. PubMed ID: 14145288
    [No Abstract]   [Full Text] [Related]  

  • 22. [A manageable and effective treatment of functional uterine hemorrhage: epsilon-aminocaproic acid].
    Bostard P
    Therapeutique; 1969 May; 45(5):546-7. PubMed ID: 5791839
    [No Abstract]   [Full Text] [Related]  

  • 23. [Trial of a phlebotonic agent, a protector of the microcirculation, containing large quantities of active principles, in the treatment of hemorrhage in obstetrics].
    Vankemmel P; Le Tallec P
    Lille Med; 1981; 26(1-2):60-2. PubMed ID: 7206996
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dicynone in gynecologic therapeutics].
    Michel J; Cloetens W
    Brux Med; 1971 Feb; 51(2):105-10. PubMed ID: 5102016
    [No Abstract]   [Full Text] [Related]  

  • 25. [A non-hormonal therapeutic agent in menorrhagia. Clinical trial of Daflon].
    Darmaillacq R; Sentenac J
    Bord Med; 1972 Jan; 5(1):71-6. PubMed ID: 5012483
    [No Abstract]   [Full Text] [Related]  

  • 26. [Trial treatment of genital hemorrhages with Dicynone].
    Gaudefroy M; Debienne-Wibaux A
    J Sci Med Lille; 1968 Oct; 86(10):629-39. PubMed ID: 5757879
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methods of rational treatment of pre-climacteric hemorrhage (author's transl)].
    Stehlík R; Beer O; Mares J
    Cesk Gynekol; 1973 Sep; 38(8):630-2. PubMed ID: 4765146
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic efficacy of functioning mammary gland extract in hemorrhagic metropathies].
    Samuel S; Mele G
    Minerva Ginecol; 1972 Jan; 24(1):28-34. PubMed ID: 4603918
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hormonal treatment of some forms of functional uterine hemorrhages].
    Zaĭtsev MA
    Pediatr Akus Ginekol; 1967; 2():58-60. PubMed ID: 5610534
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current news in the treatment with mammary gland extracts].
    Grossi F
    Minerva Ginecol; 1975 Aug; 27(8):659-64. PubMed ID: 1221324
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of ovulation inhibitors in the treatment of pathological uterine hemorrhage in women with hemorrhagic diathesis].
    R0ak K
    Orv Hetil; 1967 Nov; 108(45):2116-20. PubMed ID: 5594940
    [No Abstract]   [Full Text] [Related]  

  • 32. [The synthetic estrogen-progestagens in therapy of menometrorrhagia of puberty].
    Giambanco V; Di Grigoli D
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1523-33. PubMed ID: 5744195
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic action of a combination of functioning mammary gland extract and methyltestosterone].
    Borzone M; Cardone A
    Minerva Ginecol; 1976 May; 28(5):439-46. PubMed ID: 1035411
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes operating in capillary resistance and permeability in atherosclerotic patients under the effect of vitamins C and P].
    Chunakova EP; Prostiakov KM; Mirer ML
    Vopr Pitan; 1966; 25(3):23-9. PubMed ID: 6003571
    [No Abstract]   [Full Text] [Related]  

  • 35. [Observation of coagulation factors in memometrorrhagias treated with antifibrinolytic agents].
    Koutský J; Padovec J; Dimitrovová K; Janele J; Kastilová B
    Cesk Gynekol; 1968 Sep; 33(7):492-6. PubMed ID: 5683907
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experience with Diazepam in threatened abortion].
    Kawakami H; Yoshida S; Yoshida T; Makita M; Watanabe M
    Sanfujinka No Jissai; 1966 Mar; 15(3):270-7. PubMed ID: 6013899
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
    Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
    Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical use of Intacerin in threatened abortion].
    Watanabe K; Okano S; Iwai K; Suzumori K
    Sanfujinka No Jissai; 1968 Nov; 17(11):1018-22. PubMed ID: 5756208
    [No Abstract]   [Full Text] [Related]  

  • 39. [Allylestrenol (Gestormon) in the treatment of threatened abortion].
    Linhart L; Roztocil A; Pilka D
    Cesk Gynekol; 1993 Apr; 58(2):71-3. PubMed ID: 8319287
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of hormonal treatment in threatened and habitual abortion].
    Tarlantas D; Moschovakis K
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):563-4. PubMed ID: 5935246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.